23andMe News

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

16:25 ET

23andMe | 8-K: 23andMe Announces CEO's Intention to Pursue a Potential Take-Private

Apr 18 08:11 ET

23andMe | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anne Wojcicki(25.8%),ABeeC 2.0, LLC(23.9%), etc.

Apr 17 18:25 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Apr 5 16:20 ET

23andMe | 8-K: 23andMe CAO Kathy Hibbs Retires, Guy Chayoun Steps In

Mar 29 12:47 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Mar 22 19:23 ET

23andMe | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 22 17:09 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Mar 11 16:13 ET

23andMe | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 7 16:27 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Feb 23 17:16 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer Richards William G

Feb 21 16:45 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer Selsavage Joseph Anthony

Feb 21 16:44 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Feb 21 16:41 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Feb 16 16:52 ET

23andMe | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.24%)

Feb 13 18:17 ET

23andMe | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GSK plc(11.2%)

Feb 9 16:25 ET

23andMe | 10-Q: Quarterly report

Feb 7 16:14 ET

23andMe | 8-K: 23andMe Reports Third Quarter Fiscal 2024 Financial Results

Feb 7 16:07 ET

23andMe | 8-K: 23andme Announces Fda Clearance of Ind Application for Its Dual Mechanism Antibody, 23me-01473, Targeting Ulbp6

Jan 31 07:51 ET

23andMe | 4: Statement of changes in beneficial ownership of securities-Officer HIBBS KATHY L

Jan 26 20:26 ET